Diagnosis and Response to Treatment Using a Reliable Gastroesophageal Reflux Disease (GERD) Questionnaire: An In Clinical Practice Study

AstraZeneca250 enrolled

Overview

The purpose of the study is to determine the applicability and utility of Gerd Q in the diagnosis of GERD and in the assessment of treatment response.

Study Type

OBSERVATIONAL

Enrollment

250

Conditions

Gastroesophageal Reflux Disease

Eligibility

Sex: ALLMin age: 18 YearsMax age: 79 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients of either gender aged between 18-79 years of age * Patients must be having symptoms of gastroesophageal reflux disease Exclusion Criteria: * None

Locations (2)

Research Site

Kuala Lumpur, Malaysia

Research Site

Kuala Selangor, Malaysia

Outcomes

Primary Outcomes

To determine the applicability and utility of Gerd Q in the diagnosis of GERD and assessment of treatment response

Time frame: The applicability and utility of the Gerd Questionnaire will be done on 2 vists- Day 1 and Day 30

Secondary Outcomes

To assess and monitor the treatment response of patients diagnosed with GERD

Time frame: The monitoring and assessment of treatment response using the Gerd Questionnaire will be done on 2 vists-Day 1 and Day 30

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.